Medical disclaimer: GlucoseForge is for informational purposes only. Always consult a qualified healthcare professional.
CGM Comparison

Dexcom G7 vs Stelo 2026: Prescription vs OTC

GlucoseForge Editorial Team · Updated June 2026

Dexcom makes two CGMs — the prescription G7 and the OTC Stelo. They share the Dexcom brand and Clarity platform but serve fundamentally different users at very different price points. This comparison helps you decide which (if either) is the right Dexcom device.

GlucoseForge may earn a commission from links on this page. See our Affiliate Disclosure.
⚠️

Medical Disclaimer: This content is for informational purposes only. Always consult your healthcare provider before making health decisions.

Quick verdict

The G7 and Stelo are not competing products — they serve different users. Get the G7 if you have a prescription, use AID systems, or need clinical-grade monitoring. Get Stelo if you want Dexcom's platform OTC without a prescription. If cost is your priority and you don't need Dexcom specifically, Abbott Lingo at $89/month is the cheaper option, though Stelo's published MARD range is the lower (better) one.

Dexcom G7 vs Stelo: full comparison

AttributeDexcom G7Dexcom Stelo
MARD accuracy8.2%7.3–9.1%
Sensor life10 days15 days
Reading intervalEvery 5 minEvery 5 min
Calibration requiredNoneNone
Warm-up time30 min30 min
Retail price/month~$350~$99
With insuranceOften $0–50Not covered (OTC)
Prescription requiredYesNo
AID system compatibleYes — multiple systemsNo
Apple Watch directYesVia iPhone only
Dexcom ClarityYes — full clinicalYes — wellness mode
Wear locationArm or abdomenBack of upper arm only
Intended userDiabetes managementWellness, non-diabetics
Compare G7 and Stelo costs for your period

With and without insurance — plus every alternative.

CGM Cost Calculator →

The key difference: who each device is for

The G7 and Stelo are not interchangeable options at different price points — they are designed for different users and cleared by the FDA for different purposes.

Dexcom G7 is cleared for diabetes management including insulin dosing decisions. It integrates with AID systems, supports data sharing with clinicians through Clarity, and is covered by insurance for qualifying patients. It requires a prescription.

Dexcom Stelo is cleared for wellness monitoring in people without insulin-treated diabetes. It cannot be used to guide insulin dosing, is not covered by insurance, and requires no prescription. It uses similar sensor technology to the G7 but with a different calibration profile optimised for non-diabetic glucose ranges.

When to choose G7 over Stelo

Choose the G7 if you have a diabetes diagnosis and a prescription, use or plan to use an AID system, need to share data with your healthcare provider through Clarity's clinical interface, or want to wear the sensor on your abdomen as well as your arm.

When to choose Stelo over G7

Choose Stelo if you don't have insulin-treated diabetes, don't have or don't want a prescription, specifically want the Dexcom ecosystem and Clarity platform, and need the longest sensor life of any OTC device (15 days). If you don't specifically need Dexcom, Abbott Lingo at $89/month offers a lower price, though Stelo's published MARD range is the lower (better) one of the two.

Frequently asked questions

What is the difference between Dexcom G7 and Stelo?
The G7 is a prescription CGM cleared for diabetes management including insulin dosing decisions, with AID system compatibility and clinical Clarity integration. Stelo is an OTC CGM for wellness monitoring without a prescription, not cleared for insulin dosing, and not AID-compatible. G7 costs ~$350/month; Stelo costs ~$99/month. G7 is often covered by insurance; Stelo is not.
Is Dexcom Stelo as accurate as G7?
The G7 reports a single MARD figure (8.2%) versus Stelo's range (7.3–9.1%), which aren't strictly comparable, but G7 is a prescription clinical device with a narrower, well-characterized figure. Among OTC devices, Stelo's published range (7.3–9.1% MARD) is lower than Abbott Lingo's (8.1–10.7% MARD) at $89/month. If accuracy is your priority for OTC use, Stelo has the better-published range; if price is your priority, Lingo is cheaper.
Can Dexcom Stelo be used for diabetes management?
No. Dexcom Stelo is FDA-cleared for wellness monitoring only and is not indicated for use in diabetes management or insulin dosing decisions. People with insulin-treated diabetes should use the Dexcom G7 or another clinically cleared device.
Does Dexcom Stelo work with AID systems?
No. Dexcom Stelo is not compatible with automated insulin delivery (AID) systems. Closed-loop insulin delivery systems require Dexcom G7.
Is there a cheaper alternative to Dexcom Stelo?
Yes — Abbott Lingo at ~$89/month is OTC, requires no prescription, and is the lower-priced option (its published MARD range, 8.1–10.7%, is higher/less favorable than Stelo's 7.3–9.1%). If price matters more to you than the published accuracy range, Lingo is the better value; if the published accuracy range matters more, Stelo is the stronger choice. See our full Stelo vs Lingo comparison.
Calculate exact costs for your monitoring period

Every device side by side — 30, 90, or 365 days.

CGM Cost Calculator →

Compare all Dexcom and Abbott devices

Full specifications, costs, and head-to-head comparisons for every CGM in 2026.

Compare all CGM devices →